Trial of acute femoral fracture fixation
ISRCTN | ISRCTN92089567 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN92089567 |
Secondary identifying numbers | TrAFFix |
- Submission date
- 26/05/2016
- Registration date
- 26/05/2016
- Last edited
- 14/06/2023
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Musculoskeletal Diseases
Plain English summary of protocol
Background and study aims
The knee is the largest weight-bearing joint in the body, where the shin bone (tibia) and thigh bone (femur) meet. As people age bones naturally weaken, and so the elderly are particularly vulnerable to knee pain and injury. Every year, many older adults in the UK suffer from distal femur fractures (a fracture at the end of the thigh bone, just above the knee joint). In most cases, the main treatment offered is surgical fixation. This is an operation in which the broken pieces of bone are lined up, and held in place with wires, screws or metal plates. This study will be looking at two common surgical fixation operations for patients with distal femur fractures: 'locking plate fixation' where a plate is screwed to the surface of the bone, and 'nail fixation' where a rod is inserted into the centre of the bone. The aim of this study is to find out whether a larger scale study comparing the effectiveness of these two techniques would be feasible
Who can participate?
Adults with a fractured femur which the attending surgeon feels would benefit from surgery to fix the fracture.
What does the study involve?
Participants are randomly allocated to one of two groups. Those in the first group undergo the 'locking plate fixation' procedure, in which a plate is screwed to the surface of the bone on either side of the break. Those in the second group undergo the 'nail fixation' procedure, in which a rod is inserted into the centre of the bone on either side of the break to hold the broken pieces together. Participants in both groups are followed up six weeks and four months later in order to determine how effective the treatment has been in terms of quality of life and disability. The amount of participants who were able to be recruited to the trial and the costs of conducting the trial are also recorded in order to find out whether a larger scale trial would be possible.
What are the possible benefits and risks of participating?
As with any major operation, surgery carries some risks of bleeding, blood clots, damage to nerves and blood vessels, and risks associated with anaesthetic. These risks are similar for both treatment options and are the same if patients choose not to participate in this research. There are no specific benefits to taking part in this trial. However, the information that we get from this trial should help us with the development of the bigger trial, which we hope will ultimately provide an answer about the most suitable treatment for this type of injury.
Where is the study run from?
Seven NHS Trusts in England (UK)
When is the study starting and how long is it expected to run for?
July 2015 to December 2016
Who is funding the study?
National Institute for Health Research (UK)
Who is the main contact?
Dr Robin Lerner
traffix@ndorms.ox.ac.uk
Contact information
Public
Oxford Trauma
Kadoorie Centre
John Radcliffe Hospital
Oxford
OX3 9DU
United Kingdom
Phone | +44 1865 227912 |
---|---|
traffix@ndorms.ox.ac.uk |
Study information
Study design | Multi-centre feasibility randomised parallel trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised parallel trial |
Study setting(s) | Hospital |
Study type | Quality of life |
Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
Scientific title | For patients with an acute fragility fracture of the distal femur, is there a clinical and cost-effectiveness difference between locking plate fixation and retrograde intramedullary nail fixation? |
Study acronym | TrAFFix |
Study objectives | The aim of this study is to investigate the feasibility of running a large definitive study comparing the effectiveness of two common operations for patients with distal femur fracture (locking plate fixation and nail fixation). |
Ethics approval(s) | Wales Research Ethics Committee 5, 01/08/2016 , ref: 16/WA/0225 |
Health condition(s) or problem(s) studied | Fragility fractures of the distal femur |
Intervention | Randomisation will be via a web based secure randomisation service, and will take into account the hospital and cognitive status of the patient. This will make sure that around the same number of patients with cognitive impairment are randomised to each arm, and that each hospital treats around the same number of patients in each arm. Participants will undergo surgery at the next available opportunity on a planned trauma list. Exact surgical procedures, including X-rays and imaging, will be as per local guidelines. Following fixation all patients will undergo a routine rehabilitation programme prior to discharge from hospital. Patients will be randomised to fracture fixation with either a locking plate or intramedullary nail: Locking plate fixation: Fixation of the fracture will be achieved with anatomical distal femoral locking-plate and screws. Locking plates will be defined as those in which at least one fixed angle locking screw is placed distal to the fracture. The operating surgeon will determine the length, number and type of additional screws. The details of surgical incision and approach, fracture reduction, number and type of other screws and supplementary fixation with wires or screws will be at the surgeon’s discretion as per their normal clinical practice. Intramedullary nail fixation: Fixation of the fracture will be achieved with a proximally and distally locked nail that spans the entire diaphysis of the femur. All nails will be introduced retrograde through the knee joint. The details of surgical incision and approach, fracture reduction, number and type of other screws and supplementary fixation with wires or screws will be at the surgeon’s discretion as per their normal clinical practice. Follow-up will be at 6 weeks and 4 months after the injury when the questionnaires will be completed again. |
Intervention type | Procedure/Surgery |
Primary outcome measure | 1. Recruitment rate, calculated throughout the study and determined as the number of eligible participants who gave consent to participate 2. Completion rate of the EQ-5D-5L is measured 4 months post injury |
Secondary outcome measures | 1. Demential Quality of Life questionnaire (DEMQoL) at baseline, 6-weeks post injury, and 4-months post-injury 2. Disability rating index (DRI) at baseline, 6-weeks post injury, and 4-months post-injury 3. Mixed methods analysis of a process evaluation, including patient and staff interviews throughout the length of the trial |
Overall study start date | 14/07/2015 |
Completion date | 28/02/2018 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Sex | Both |
Target number of participants | 52 |
Total final enrolment | 23 |
Key inclusion criteria | 1. Patients of 18 years old and above 2. Present to participating hospitals with a fracture of the distal femur (i.e. involving the distal 2 "Muller" squares) 3. Attending surgeon feels that the patient will benefit from internal fixation of the fracture |
Key exclusion criteria | 1. Patients who have a knee or hip arthroplasty that requires revision 2. A pre-existing arthroplasty that precludes fixation with an intramedullary nail 3. Patients with pre-existing femoral deformity will also be excluded |
Date of first enrolment | 14/10/2016 |
Date of final enrolment | 31/07/2017 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centres
London Road
Reading
RG15AN
United Kingdom
Headley Way
Headington
Oxford
OX3 9DU
United Kingdom
Beckett Street
Leeds
LS9 7TF
United Kingdom
Derby Road
Nottingham
NG7 2UH
United Kingdom
Southwick Hill Road
Portsmouth
PO6 3LY
United Kingdom
Gwendolen Road
Leicester
LE5 4QF
United Kingdom
Stoke-on-Trent
ST4 6QG
United Kingdom
Sponsor information
University/education
Joint Research Office
Block 60
Churchill Hospital
Old Road
Headington
Oxford
OX3 7LE
England
United Kingdom
https://ror.org/052gg0110 |
Funders
Funder type
Government
Government organisation / National government
- Alternative name(s)
- National Institute for Health Research, NIHR Research, NIHRresearch, NIHR - National Institute for Health Research, NIHR (The National Institute for Health and Care Research), NIHR
- Location
- United Kingdom
Results and Publications
Intention to publish date | 28/02/2019 |
---|---|
Individual participant data (IPD) Intention to share | Yes |
IPD sharing plan summary | Available on request |
Publication and dissemination plan | The study monograph will be prepared by the trial management team at the completion of the trial. There are currently no specific plans for publishing the study results. |
IPD sharing plan | Pseudo-anonymised participant level data will be available on application to the Chief Investigator, once any future definitive study that uses this data has been completed. |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Protocol article | protocol | 14/11/2017 | Yes | No | |
Results article | results | 01/09/2019 | 27/09/2019 | Yes | No |
Results article | results | 05/05/2019 | 04/06/2020 | Yes | No |
Results article | feasibility results | 22/07/2019 | 14/06/2023 | Yes | No |
Results article | mixed methods process evaluation | 09/08/2019 | 14/06/2023 | Yes | No |
HRA research summary | 28/06/2023 | No | No |
Editorial Notes
14/06/2023: Publication references added.
04/06/2020: Publication reference added.
27/09/2019: Publication reference and total final enrolment number added.
11/02/2019: The main contact email was added: traffix@ndorms.ox.ac.uk
16/11/2017: Publication reference added.
23/10/2017: Internal review.
31/08/2017: Ethics approval information has been added.
15/05/2017: The IPD sharing statement has been added as well as the benefits and risks of participating to the plain English summary.
11/05/2017: The overall trial end date has been updated from 01/08/2016 to 28/02/2018 and the recruitment end date has been updated from 31/05/2017 to 31/07/2017. In addition, the first inclusion criteria has recently been amended to “Patients of 18 years old and above” instead of 50 and University Hospitals of North Midlands NHS Trust has been added to the list of trial participating centres.